Skip Navigation, or press ALT and K together and then press enter.Welcome to the OMC website. This site has been developed for both the visually impaired and non visually impaired. If you would like to use the visually impaired version of this site please go to omc.gov.ie/viewtxt.asp, or press ALT and I together and then press enter

Irish Child Health Database - Peer Reviewed Papers

Database Search


You are here: Irish Child Health Database » Study Papers » Descriptive Studies - Without a comparision » Case Study
  • Outcome of infants born to hepatitis C infected women

    Published in:

    Ir J Med Sci, Vol: 170, Page: 103-6; discussion 92-3

    Publication Date:

    2001 Apr-Jun

    Aims & Objectives:

    The aim of this study was to examine outcomes of infants born to Hepatitis C virus infected women, to characterise epidemiology and to design an appropriate infant monitoring schedule

    Abstract:

    BACKGROUND: Hepatitis C virus (HCV) can be transmitted vertically from mother to infant, either late in pregnancy or at delivery. AIMS: To determine the outcome of infants born to HCV infected women, to characterise epidemiology and to design an appropriate infant monitoring schedule. METHODS: Three hundred and fourteen infants, born to 296 HCV positive women between 1994 and 1999 were monitored for a median of 18 months (range 1-52). RESULTS: Forty per cent of infants were small for age and 46% had neonatal abstinence syndrome (NAS). Of 173 infants of defined status, 11 were infected (vertical transmission rate [VTR] 6.4%, 95% CI 2.8-10). Infected infants were diagnosed at a median of three months (range 0.5-10). Liver transaminases elevation was documented in 8% of uninfected infants. A negative HCV PCR test before one month of age did not exclude infection but all infected patients had detectable HCV RNA when next tested (range 2-10 months). CONCLUSIONS: 94% of infants born to HCV antibody positive women are not HIV infected. Liver transaminase elevation in exposed infants is not always indicative of infection. A minimum monitoring schedule of testing (PCR and antibody) at six to eight weeks, six and 18 months allows early diagnosis while detecting late seroconversions.

    Authors:

    C. M. Healy; M. T. Cafferkey; A. Conroy; S. Dooley; W. W. Hall; M. Beckett; T. A. Clarke; M. J. White; W. A. Gorman; K. M. Butler

    Study Type:

    Study Papers » Case Study » Descriptive Studies - Without a comparision

    Categories:

    hepatitis C

    International Classification:

    Certain infectious and parasitic diseases - Viral hepatitis - hepatitis C

    Keywords:


    Geography:

    Republic of Ireland (Republic of Ireland)